Healthcare: Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6 • 854 Ratings

🗓️ 16 August 2017

⏱️ 30 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players.

Transcript

Click on a timestamp to play from that location

0:00.0	This episode of Industry Focus is brought to you by 23 and Me.com.
0:04.0	With 23 and Me's Genetic Service, you can learn what percentage of your DNA
0:08.0	comes from places like Italy, Finland, East Asia, or Africa.
0:12.0	Visit 23 and Me.com slash Fool.
0:14.5	That is the number 23, A and D.M. E.
0:17.8	dot com slash fool.
0:19.6	Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.
0:26.5	I'm your health care show host, Christine Hargis. It is August 16th, and I have health care specialist Todd Campbell on the line.
0:33.0	Todd, you are just returning from a trip to Cape Cod.
0:36.0	How was it?
0:37.0	It was great.
0:38.0	And you know, I don't know if when you travel you're always looking for investment ideas.
0:41.0	I always am, no matter what I'm doing when I'm traveling
0:45.6	or if I'm going to the dentist or whatever I'm trying to figure out if there's an
0:48.9	investing angle and I have one for you Christine.. Okay, let's hear it.
0:53.0	Go long, Well Fleet Oysters.
0:55.4	Oh my God, they're so delicious.
0:57.0	Is that an actual company?
0:59.2	No.
1:00.4	But they are delicious oysters. Maybe someday they'll go public and then we can make all of the riches.
1:06.0	There we go.
1:07.0	Yum, sounds really good.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.